-
EP3601239
European procedure
Extract from the Register of European Patents
EP Citations: EP3601239
| Cited in | Search | Type: | Patent literature | Publication No.: | WO2016203406
[XP] (NOVARTIS AG et al.) [XP] 1-3,6,8,11,12,15-18,20,21,26,38-43 | Type: | Patent literature | Publication No.: | WO2015107495
[XA] (NOVARTIS AG et al.) [X] 1-4,9,15-17,22,23,26,38-43 * formula Ia with p = q =1;; claims 1-10,12-14 *[A] 6-8,10-14,18-21,24,25,27-37 | Type: | Patent literature | Publication No.: | WO2017211303
[XA] (JACOBIO PHARMACEUTICALS CO LTD et al.) [X] 1-4,9,15-17,22,23,26,38-43 * paragraphs [0029] , [0033]; claims 2-9, 22-23 *[A] 6-8,10-14,18-21,24,25,27-37 | Type: | Patent literature | Publication No.: | WO2007057775
[XP] (PFIZER LTD et al.) [XP] 1-3,6,8,11,12,15-18,20,21,26,38-43 * claims 1,29,35 * | Cited in | International search | Type: | Patent literature | Publication No.: | WO2018013597
[PX] (REVOLUTION MEDICINES INC et al.) [PX] 1-130 * claims, examples * | Type: | Patent literature | Publication No.: | WO2016203406
[X] (NOVARTIS AG et al.) [X] 1-130 * claims 1, 4-14, examples * | Type: | Patent literature | Publication No.: | WO2015107495
[X] (NOVARTIS AG et al.) [X] 1-130 * examples, claims * | Type: | Patent literature | Publication No.: | WO2015107494
[A] (NOVARTIS AG et al.) [A] 1-130 * claims, examples * | Cited in | Examination | Type: | Patent literature | Publication No.: | WO2017211303
| Cited in | by applicant | Type: | Patent literature | Publication No.: | WO2017211303
| Type: | Non-patent literature | Publication information: | "Design of Prodrugs", 1985, ELSEVIER | Type: | Non-patent literature | Publication information: | Y. UTO ET AL., BIOORG. MED. CHEM. LETT., vol. 20, 2010, pages 746 - 754 | Type: | Non-patent literature | Publication information: | J. ORG. CHEM., vol. 64, 1999, pages 5504 - 5510 | Type: | Non-patent literature | Publication information: | "REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY", 1995, MACK PUBLISHING CO. |